Kyoung Tae Jung

Title: Kyoung Tae Jung: Innovator in Oral Film Dosage Technology

Introduction

Kyoung Tae Jung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of oral dosage forms. His innovative approach focuses on enhancing patient experience through improved medication delivery systems.

Latest Patents

Kyoung Tae Jung holds a patent for a quickly soluble oral film dosage containing steviosides as an unpleasant taste masking agent. This invention is designed to efficiently mask the bitter or unpleasant taste of medications. The quickly soluble oral film dosage comprises a stevioside-based sweetener and a high potency sweetener in a weight ratio of 1:3 to 3:1. This formulation allows for rapid dissolution in the mouth without the need for water, thereby improving the aftertaste and enhancing dosage acceptability for patients. He has 1 patent to his name.

Career Highlights

Kyoung Tae Jung is associated with Chabio & Diostech Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing solutions that improve the overall experience of medication intake for patients.

Collaborations

Kyoung Tae Jung has collaborated with notable colleagues in his field, including Jin-Kyu Park and Won-Suk Yang. Their combined expertise contributes to the advancement of innovative pharmaceutical technologies.

Conclusion

Kyoung Tae Jung's contributions to the field of oral film dosage technology highlight his commitment to improving patient care through innovation. His work exemplifies the importance of addressing patient needs in medication delivery systems.